Hetero Healthcare to supply 20,000 vials of Covid-19 drug Co
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Popular pharmaceutical company Hetero Healthcare on Wednesday said that it is all set to deliver 20,000 vials of its antiviral drug Covifor (remdesivir) across the country for the treatment of COVID-19.

• The company said it has fixed a maximum retail price of Rs 5,400 per vial for the drug.

• “Following the approval of Covifor, the generic of Remdesivir by DCGI, the company is set to deliver the first set of 20,000 vials,” Hetero Healthcare said in a statement.

• "Through Covifor, we hope to reduce the treatment time of a patient in a hospital, thereby reducing the increasing pressure on the medical infrastructure, overburdened currently due to accelerating COVID-19 cases,” Hetero Healthcare MD M Srinivasa Reddy said.

• Covifor is the generic brand of remdesivir, indicated for the treatment of COVID-19 patients in adults and children, hospitalized with severe symptoms of the disease, the statement said.

• The drug is available in 100 mg vial (injectable). It needs to be administered intravenously in a hospital, critical care setting, under the supervision of a registered medical practitioner, it added.

Source: https://www.thehindu.com/news/national/hetero-healthcare-set-to-supply-its-generic-covid-19-drug-covifor-at-5400-per-vial-across-india/article31906010.ece
Like
Comment
Share